Vildagliptin/Metformin Rivopharm

Vildagliptin/Metformin Rivopharm combines two oral diabetes medications to support blood sugar control. This combination therapy is prescribed for type 2 diabetes management when diet and exercise alone are insufficient. It is designed for oral use and manufactured in the EU.

Vildagliptin/Metformin Rivopharm is used to improve blood sugar levels in adults with type 2 diabetes. It combines metformin, which reduces glucose production in the liver, with vildagliptin, which enhances insulin production after meals. This combination helps maintain stable blood sugar throughout the day.

This medication helps regulate blood sugar by working on both liver glucose output and pancreatic insulin response. Users may notice steadier energy levels and reduced sugar cravings as blood sugar stabilizes. Individual responses vary based on diet, activity, and metabolism.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. If you experience persistent nausea, dizziness, or unusual fatigue, consult a healthcare provider. Always inform your doctor about all medications and supplements you are taking.

Alcohol may increase the risk of lactic acidosis when combined with metformin. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. Always discuss your full medication list with your doctor to avoid potential interactions.